A RIETE registry analysis of recurrent thromboembolism and hemorrhage in patients with catheter-related thrombosis

Journal of Vascular Surgery: Venous and Lymphatic Disorders

Volumn 3, Issue 3, 2015, Pages 243-250.e1

  Baumann Kreuziger, Lisa ^a   Cote, Lauren ^b   Verhamme, Peter ^c   Greenberg, Steven ^b   Caprini, Joseph ^b,d   Muñoz, Francisco José ^e   Valle, Reina ^f   Monreal Bosch, Manuel ^g  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b NORTHSHORE UNIVERSITY HEALTHSYSTEM   (United States)

^c UNIVERSITY OF LEUVEN   (Belgium)

^d UNIVERSITY OF CHICAGO   (United States)

^e Hospital de Mollet   (Spain)

^f HOSPITAL SIERRALLANA   (Spain)

^g HOSPITAL UNIVERSITARI GERMANS TRIAS I PUJOL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIVITAMIN K; ESTROGEN; HEPARIN; LOW MOLECULAR WEIGHT HEPARIN; PHOSPHOLIPID ANTIBODY;

ADULT; AGE; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BODY WEIGHT; CATHETER THROMBOSIS; DEEP VEIN THROMBOSIS; DISEASE ASSOCIATION; EXPOSURE; FEMALE; HIGH RISK PATIENT; HOSPITAL PATIENT; HUMAN; IMMOBILITY; KIDNEY FAILURE; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; MORTALITY; NEOPLASM; OUTCOME ASSESSMENT; PREGNANCY; PRIORITY JOURNAL; RECURRENT DISEASE; REGISTER; RISK FACTOR; THROMBOEMBOLISM; THROMBOPHILIA; TREATMENT DURATION; VENOUS THROMBOEMBOLISM; ADVERSE DEVICE EFFECT; CATHETER; THROMBOSIS; VEIN THROMBOSIS;

CATHETERS; HEMORRHAGE; HUMANS; PULMONARY EMBOLISM; RECURRENCE; REGISTRIES; THROMBOSIS; VENOUS THROMBOSIS;

EID: 84931046568     PISSN: 2213333X     EISSN: 22133348     Source Type: Journal    
DOI: 10.1016/j.jvsv.2015.03.002     Document Type: Article

References (32)

1. A.K. Jha, I. Larizgoitia, C. Audera-Lopez, N. Prasopa-Plaizier, H. Waters, and D.W. Bates The global burden of unsafe medical care: analytic modelling of observational studies BMJ Qual Saf 22 2013 809 815
2. M.A. Jones, D.Y. Lee, J.A. Segall, G.J. Landry, T.K. Liem, and E.L. Mitchell Characterizing resolution of catheter-associated upper extremity deep venous thrombosis J Vasc Surg 51 2010 108 113
3. V. Chopra, S. Anand, A. Hickner, M. Buist, M.A. Rogers, and S. Saint Risk of venous thromboembolism associated with peripherally inserted central catheters: a systematic review and meta-analysis Lancet 382 2013 311 325
4. B. Linnemann, and E. Lindhoff-Last Risk factors, management and primary prevention of thrombotic complications related to the use of central venous catheters Vasa 41 2012 319 332
5. C.A. Owens, J.T. Bui, M.G. Knuttinen, R.C. Gaba, and T.C. Carrillo Pulmonary embolism from upper extremity deep vein thrombosis and the role of superior vena cava filters: a review of the literature J Vasc Interv Radiol 21 2010 779 787
6. J.A. Lee, B.K. Zierler, and R.E. Zierler The risk factors and clinical outcomes of upper extremity deep vein thrombosis Vasc Endovascular Surg 46 2012 139 144
7. A. Aw, M. Carrier, J. Koczerginski, S. McDiarmid, and J. Tay Incidence and predictive factors of symptomatic thrombosis related to peripherally inserted central catheters in chemotherapy patients Thromb Res 130 2012 323 326
8. V. Chopra, D. Ratz, L. Kuhn, T. Lopus, A. Lee, and S. Krein Peripherally inserted central catheter-related deep vein thrombosis: contemporary patterns and predictors J Thromb Haemost 12 2014 847 854
9. G.S. Patel, K. Jain, R. Kumar, A.H. Strickland, L. Pellegrini, and J. Slavotinek Comparison of peripherally inserted central venous catheters vs subcutaneously implanted port-chamber catheters by complication and cost for patients receiving chemotherapy for non-haematological malignancies Support Care Cancer 22 2014 121 128
10. L.J. Worth, J.F. Seymour, and M.A. Slavin Infective and thrombotic complications of central venous catheters in patients with hematological malignancy: prospective evaluation of nontunneled devices Support Care Cancer 17 2009 811 818
11. M. Verso, and G. Agnelli Venous thromboembolism associated with long-term use of central venous catheters in cancer patients J Clin Oncol 21 2003 3665 3675
12. D.J. Kuter Thrombotic complications of central venous catheters in cancer patients Oncologist 9 2004 207 216
13. M. Roselli, P. Ferroni, S. Riondino, S. Mariotti, A. Laudisi, and M. Vergati Impact of chemotherapy on activated protein C-dependent thrombin generation - association with VTE occurrence Int J Cancer 133 2013 1253 1258
14. A.A. Khorana, N.M. Kuderer, E. Culakova, G.H. Lyman, and C.W. Francis Development and validation of a predictive model for chemotherapy-associated thrombosis Blood 111 2008 4902 4907
15. M.L. Louzada, M. Carrier, A. Lazo-Langner, V. Dao, M.J. Kovacs, and T.O. Ramsay Development of a clinical prediction rule for risk stratification of recurrent venous thromboembolism in patients with cancer-associated venous thromboembolism Circulation 126 2012 448 454
16. P. Debourdeau, D. Farge, M. Beckers, C. Baglin, R.M. Bauersachs, and B. Brenner International clinical practice guidelines for the treatment and prophylaxis of thrombosis associated with central venous catheters in patients with cancer J Thromb Haemost 11 2013 71 80
17. C. Kearon, E.A. Akl, A.J. Comerota, P. Prandoni, H. Bounameaux, and S.Z. Goldhaber Antithrombotic therapy for VTE disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines Chest 141 2012 e419S e494S
18. C. Suarez Fernandez, J.A. Gonzalez-Fajardo, and M. Monreal Bosch [Computerized registry of patients with thromboembolic disease in Spain (RIETE): background, objectives, methods, and preliminary results] Rev Clin Esp 203 2003 68 73
19. M. Monreal, C. Suarez, J.A. Fajardo, R. Barba, F. Uresandi, and R. Valle Management of patients with acute venous thromboembolism: findings from the RIETE registry Pathophysiol Haemost Thromb 33 2003 330 334
20. S. Schulman, and C. Kearon Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients J Thromb Haemost 3 2005 692 694
21. M.J. Kovacs, S.R. Kahn, M. Rodger, D.R. Anderson, R. Andreou, and J.E. Mangel A pilot study of central venous catheter survival in cancer patients using low-molecular-weight heparin (dalteparin) and warfarin without catheter removal for the treatment of upper extremity deep vein thrombosis (The Catheter Study) J Thromb Haemost 5 2007 1650 1653
22. P.L. Massoure, J. Constans, M. Caudry, P. Morlat, S. Skopinski, and J. Beylot [Upper extremity deep venous thrombosis. 40 hospitalized patients] J Mal Vasc 25 2000 250 255
23. J.A. Heit Predicting the risk of venous thromboembolism recurrence Am J Hematol 87 Suppl 1 2012 S63 S67
24. A. Iorio, C. Kearon, E. Filippucci, M. Marcucci, A. Macura, and V. Pengo Risk of recurrence after a first episode of symptomatic venous thromboembolism provoked by a transient risk factor: a systematic review Arch Intern Med 170 2010 1710 1716
25. L. Eischer, S. Eichinger, and P.A. Kyrle The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study J Thromb Haemost 12 2014 635 640
26. A. Delluc, G. Le Gal, D. Scarvelis, and M. Carrier Outcome of central venous catheter associated upper extremity deep vein thrombosis in cancer patients Thromb Res 135 2015 298 302
27. T.M. Kerr, K.S. Lutter, D.M. Moeller, K.A. Hasselfeld, L.R. Roedersheimer, and P.J. McKenna Upper extremity venous thrombosis diagnosed by duplex scanning Am J Surg 160 1990 202 206
28. J. Murray, E. Precious, and R. Alikhan Catheter-related thrombosis in cancer patients Br J Haematol 162 2013 748 757
29. T. Baglin, J. Douketis, A. Tosetto, M. Marcucci, M. Cushman, and P. Kyrle Does the clinical presentation and extent of venous thrombosis predict likelihood and type of recurrence? A patient-level meta-analysis J Thromb Haemost 8 2010 2436 2442
30. P. Prandoni, A.W. Lensing, A. Piccioli, E. Bernardi, P. Simioni, and B. Girolami Recurrent venous thromboembolism and bleeding complications during anticoagulant treatment in patients with cancer and venous thrombosis Blood 100 2002 3484 3488
31. A.Y. Lee, M.N. Levine, R.I. Baker, C. Bowden, A.K. Kakkar, and M. Prins Low-molecular-weight heparin versus a coumarin for the prevention of recurrent venous thromboembolism in patients with cancer N Engl J Med 349 2003 146 153
32. F.J. Munoz, P. Mismetti, R. Poggio, R. Valle, M. Barron, and M. Guil Clinical outcome of patients with upper-extremity deep vein thrombosis: results from the RIETE Registry Chest 133 2008 143 148